Detalhe da pesquisa
1.
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
N Engl J Med
; 376(9): 836-847, 2017 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28249141
2.
Stopping guidelines for harm in a study designed to establish the safety of a marketed drug.
J Biopharm Stat
; 22(2): 338-50, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22251178
3.
A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies.
Cardiol Ther
; 9(2): 447-465, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564340
4.
Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.
J Clin Oncol
; 27(17): 2838-47, 2009 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19380447
5.
A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.
Cancer
; 97(5): 1312-20, 2003 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12599240